IPCALAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > ipcalab

Technical Analysis

Technical Strength: 6.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 51.6. According to RSI analysis, ipcalab is technically strong. 9.0 IPCALAB RSI Chart
MACD (?) MACD: 13.8 and Signal Line: 13.8. According to MACD analysis, ipcalab is technically strong. 8.0 IPCALAB MACD Chart
Simple Moving Average (?) According to simple moving average analysis, ipcalab is in a strong uptrend. Major support levels are 692.6275, 673.607, 554.81. 10.0 IPCALAB Simple Moving Average Chart
Exponential Moving Average (?) Price just got below it's 20-day exponential moving average which is a negative signal. According to exponential moving average analysis, ipcalab is facing resistance from it's 20-day exponential moving average at 696.6098 and support level is at 669. 2.0 IPCALAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.524. 5.0 IPCALAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 685.846 and 668.5. Resistance level is 742.0. 6.5 IPCALAB Fibonacci Retracement Chart
Average True Range (?) ATR: 23.7 NA IPCALAB Average True Range Chart
Average Directional Index (?) ADX is 18.9 which means IPCALAB is in a trading range and there is no trend. NA IPCALAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 25, 2018
Open Price 734.75
High Price 734.75
Low Price 690.0
Close Price 695.3
Absolute Change -39.4
Percentage Change -5.36%
Weekly Change -2.03%
Monthly Change 5.42%
Yearly Change 16.3%
52-week high 742.0
52-week low 400.0
Corporate Actions
ExDate Purpose
July 27, 2017 AGM/DIV -RE 1 PER SHARE
August 04, 2016 ANNUAL GENERAL MEETING
July 22, 2015 AGM/DIV-RE 1 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.384
Confidence in Beta0.671%
Market Capital Rs. 8773.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 7.25
TTM Price-to-Earnings (P/E) Ratio 95.9
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 25 April 2018: Deliverable Quantity:9.64e+04 NA IPCALAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 25 April 2018: Daily Volatility:0.428 NA IPCALAB Annualized Daily Volatility (Spot Price) Chart

Announcements

April 04, 2018 KayDisc. under Reg.30 of SEBI (SAST) Reg.2011ygee Investments Private Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
March 22, 2018 IPCCredit RatingCA Laboratories Limited has informed the Exchange regarding Credit Rating
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 22, 2018 February 07, 2018 IntResultster-alia, to consider and take on record the Unaudited Financial Results for the 3rd quarter and nine months ended December 31, 2017 of the financial year 2017- 18.
November 01, 2017 November 14, 2017 intResultster-alia, to consider and take on record the Unaudited Financial Results for the 2nd quarter and half year ended September 30, 2017 of the financial year 2017-18.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 633.9 Rs. 661.9 Rs. 678.6 Rs. 706.7 Rs. 723.4 Rs. 751.4 Rs. 768.1